Pirfenidone: A novel antifibrotic agent with implications for the treatment of obliterative bronchiolitis

被引：18
|
作者：
Dosanjh, AK [1 ]
Wan, B [1 ]
Throndset, W [1 ]
Sherwood, S [1 ]
Morris, RE [1 ]
机构：
[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
来源：
TRANSPLANTATION PROCEEDINGS | 1998年 / 30卷 / 05期
关键词：
D O I：
10.1016/S0041-1345(98)00478-3
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1910 / 1911
页数：2
相关论文
共 50 条
  • [41] Combined application of biosponges and an antifibrotic agent for the treatment of volumetric muscle loss
    West, Charles
    Tobo, Connor
    Au, Jeffrey
    Johnson, David
    Mottaleb, M. Abdul
    Robinson, Jessica
    Shringarpure, Saloni
    Griggs, David W.
    Garg, Koyal
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2023, 324 (06): : C1341 - C1352
  • [42] Pirfenidone: A novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production
    Lee, BS
    Margolin, SB
    Nowak, RA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01): : 219 - 223
  • [43] The effects of cytosporone-B, a novel antifibrotic agent, on vocal fold fibroblasts
    Hiwatashi, Nao
    Mukudai, Shigeyuki
    Bing, Renjie
    Branski, Ryan C.
    LARYNGOSCOPE, 2018, 128 (12): : E425 - E428
  • [44] Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice
    Aono, Y
    Nishioka, Y
    Inayama, M
    Ugai, M
    Kishi, J
    Uehara, H
    Izumi, K
    Sone, S
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (11) : 1279 - 1285
  • [45] Pirfenidone: A novel anti-fibrotic agent and progressive chronic allograft rejection
    Dosanjh, A
    Ikonen, T
    Wan, B
    Morris, RE
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2002, 15 (05) : 433 - 437
  • [46] Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
    Yadav, Hemang
    Peters, Steve G.
    Keogh, Karina A.
    Hogan, William J.
    Erwin, Patricia J.
    West, Colin P.
    Kennedy, Cassie C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (12) : 2264 - 2269
  • [47] Novel targets of antifibrotic and anti-inflammatory treatment in CKD
    Anne-Emilie Declèves
    Kumar Sharma
    Nature Reviews Nephrology, 2014, 10 : 257 - 267
  • [48] Development of obliterative bronchiolitis after allogeneic rat lung transplantation:: Implication of acute rejection and the time point of treatment
    Hirt, SW
    You, XM
    Möller, F
    Boeke, K
    Starke, M
    Spranger, U
    Wottge, HU
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (06): : 542 - 548
  • [49] The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation
    Sarahrudi, K
    Carretta, A
    Wisser, W
    Senbaklavaci, Ö
    Ploner, M
    Neuhauser, P
    Dobrovits, M
    Marta, GM
    Papp, A
    Klepetko, W
    TRANSPLANT INTERNATIONAL, 2002, 15 (01) : 24 - 28
  • [50] Novel targets of antifibrotic and anti-inflammatory treatment in CKD
    Decleves, Anne-Emilie
    Sharma, Kumar
    NATURE REVIEWS NEPHROLOGY, 2014, 10 (05) : 257 - 267
12345